AKBA
Akebia Therapeutics, Inc. · Healthcare
CEO and President John P. Butler sold $57K of Akebia Therapeutics, Inc.
Sold$57,354
$1.52Price
37,733Shares
−2%Stake
What AKBA did after the filing
- The stock from Thu, Feb 29 close, $1.58
- −7.6%
- S&P 500, same days
- +0.9%
Measured over 30 trading days, to the Apr 12 close.
Traded Tue, Feb 27. Filed Thu, Feb 29, 1:00 PM ET, during the session. Returns use the Feb 29 close and the Apr 12 close. Not investment advice.